The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.

“The iREACH intervention was effective in improving pediatric clinician adherence to the 2017 PPA guidelines for infants at high and low risk of PA,” the study authors concluded. “Wide dissemination ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.

South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

For decades, the CDC has released a yearly report tracking national abortion trends, but this year’s report has been delayed until spring.

Families of Texas children in the 2025 measles outbreak seemed to respond to a CDC recommendation for early vaccination to limit the spread.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of c ...

Dozens of units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the FDA, according to a drug safety alert issued by the Agency.

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

Heart failure associated with sarcoidosis has higher mortality risk than HF associated with ischemic heart disease or dilated cardiomyopathy.